April Xu

April Xu is an accomplished professional in the field of biopharmaceuticals, currently serving as Executive Director of Analytical R&D at BeiGene since May 2021. Previously, April held the position of Associate Research Fellow and Group Leader at Pfizer from December 2010 to August 2020, overseeing project progression and career development while representing Analytical R&D for complex modalities in clinical development. April's experience includes serving as Principal Research Scientist II and Group Leader at Wyeth Vaccines Research, where responsibilities involved developing and transferring analytical assays for vaccine candidates. Earlier in the career, April led analytical functions at Regeneron Pharmaceuticals, managing a protein core facility and supporting method development for protein therapeutics. April Xu holds a PhD, which complements a robust professional background in analytical research and development across multiple prestigious organizations.